NCT06596343View on ClinicalTrials.gov

Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Locally Advanced Colorectal CancerPostoperative Adjuvant Therapy
Interventions
DRUG

Adjuvant Chemotherapy Combined with Traditional Chinese Medicine (TCM) Supportive Therapy

"1. Chemotherapy Regimen:~ * Postoperative adjuvant chemotherapy: A dual-drug concurrent regimen will be used, with each cycle lasting 21 days. On day 1 of each cycle, oxaliplatin will be administered intravenously at a dose of 130 mg/m². From day 1 to day 14 of each cycle, capecitabine will be taken orally at a dose of 1000 mg/m², twice daily. The treatment duration will follow the CSCO 2023 guidelines for colorectal cancer, with chemotherapy lasting for 6 months.~2. TCM Treatment:~ * TCM treatment will be based on syndrome differentiation (Zheng) and guided by the Guidelines for TCM Diagnosis and Treatment of Malignant Tumors."

Trial Locations (1)

310016

Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Sir Run Run Shaw Hospital

OTHER

NCT06596343 - Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter